Displaying drugs 14726 - 14750 of 14896 in total
2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole
Experimental
3-(cyclohexylamino)propanesulfonic acid
Experimental
N-cyclohexyltaurine
Experimental
ANA971
ANA971, an orally administered prodrug of isatoribine. Isatoribine is a nucleoside analog in development for the treatment of chronic hepatitis C virus (HCV) infection. ANA971 is a prodrug designed to improve the oral bioavailability of isatoribine. ANA971 resulted in higher levels of isatoribine in the blood than were present after...
Investigational
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone
Experimental
Bis(N-maleimidomethyl)ether
Experimental
3-(N-morpholino)propanesulfonic acid
Experimental
Ghavamiol
Experimental
4-Methyl-5-Hydroxyethylthiazole Phosphate
Experimental
5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone
Experimental
1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine
Experimental
Methyl pyrrolidone
N Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.
Investigational
ETC-1001
ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Investigational
Denibulin
Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Investigational
3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline
Experimental
Displaying drugs 14726 - 14750 of 14896 in total